Man Group plc boosted its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 143.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,273 shares of the company's stock after buying an additional 24,323 shares during the quarter. Man Group plc owned approximately 0.07% of Molina Healthcare worth $12,013,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Waldron Private Wealth LLC raised its stake in Molina Healthcare by 4.7% during the fourth quarter. Waldron Private Wealth LLC now owns 729 shares of the company's stock worth $212,000 after buying an additional 33 shares during the last quarter. Angeles Investment Advisors LLC raised its position in shares of Molina Healthcare by 5.4% in the 4th quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock worth $244,000 after acquiring an additional 43 shares in the last quarter. Coldstream Capital Management Inc. lifted its stake in shares of Molina Healthcare by 2.1% in the 4th quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock valued at $683,000 after purchasing an additional 48 shares during the period. Lindbrook Capital LLC boosted its position in shares of Molina Healthcare by 38.5% during the 4th quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock valued at $60,000 after purchasing an additional 57 shares in the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC boosted its position in shares of Molina Healthcare by 7.1% during the 4th quarter. Laird Norton Wetherby Wealth Management LLC now owns 877 shares of the company's stock valued at $255,000 after purchasing an additional 58 shares in the last quarter. Institutional investors own 98.50% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on the company. Mizuho boosted their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. UBS Group dropped their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. Baird R W lowered shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Barclays lifted their price target on shares of Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a research note on Friday, April 25th. Finally, Guggenheim initiated coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Nine equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $365.38.
Get Our Latest Stock Analysis on MOH
Molina Healthcare Stock Down 3.0%
Shares of NYSE:MOH traded down $9.47 during mid-day trading on Thursday, hitting $310.15. 906,137 shares of the company traded hands, compared to its average volume of 689,862. The stock has a 50-day moving average price of $324.82 and a two-hundred day moving average price of $308.43. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $365.23. The stock has a market cap of $16.81 billion, a P/E ratio of 15.18, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same period last year, the business earned $5.73 EPS. The business's revenue was up 12.2% on a year-over-year basis. On average, equities research analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Insider Activity at Molina Healthcare
In other news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now directly owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 89,169 shares of company stock valued at $28,520,995 over the last ninety days. Corporate insiders own 1.26% of the company's stock.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.